Combined Romosozumab and Raloxifene treatment targets impaired bone quality in a male murine model of diabetic kidney disease.
Saved in:
| Title: | Combined Romosozumab and Raloxifene treatment targets impaired bone quality in a male murine model of diabetic kidney disease. |
|---|---|
| Authors: | Kohler R; Weldon School of Biomedical Engineering, Purdue University, Indianapolis, IN, United States., Segvich DM; Weldon School of Biomedical Engineering, Purdue University, Indianapolis, IN, United States., Reul O; Weldon School of Biomedical Engineering, Purdue University, Indianapolis, IN, United States., Metzger CE; Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States., Allen MR; Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States; Roudebush Veterans Administration Medical Center, Indianapolis, IN, United States., Wallace JM; Weldon School of Biomedical Engineering, Purdue University, Indianapolis, IN, United States; Roudebush Veterans Administration Medical Center, Indianapolis, IN, United States. Electronic address: jmwalla@iu.edu. |
| Source: | Bone [Bone] 2025 May; Vol. 194, pp. 117415. Date of Electronic Publication: 2025 Jan 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2763 (Electronic) Linking ISSN: 18732763 NLM ISO Abbreviation: Bone Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
